Healthcare

According to a new market report published by Lucintel, the future of the genomics personalized health market looks promising with opportunities in academics & research institutes and diagnostic centers. The global genomics personalized health market is expected to grow with a CAGR of 15% from 2020 to 2025. The major drivers for this market are rising biopharmaceutical and healthcare industries, increasing prevalence of cancer, growing geriatric population, and development in technologies.

In this market, NGS (Next Generation Sequencing) platforms, RT-PCR (Real Time Polymerase Chain Reaction), microarray, and genetic analyzers are the major technologies. Lucintel forecasts that NGS platforms will remain the largest technology segment over the forecast period, as it consists of prominent best-selling and advance sequencing products used for various genetic analysis and development of highly efficient technologies.

North America will remain the largest region over the forecast period due to increasing healthcare expenditure and growing pharmaceutical and biotechnology companies in the region.

Qiagen, Illumina, Thermo Fisher Scientific, Bio-Rad Laboratories, Roche, Lonza, Invitae, Genetic Technologies, Eastern Biotech, and DNA Genotek are among the major suppliers in the global genomics personalized health market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global genomics personalized health market by test type, technology, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Genomics Personalized Health Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global genomics personalized health market by test type, technology, end user, and region as follows:

By Test Type [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  Oncology Testing


• 
  Infectious Disease Testing


• 
  Orphan Disease Testing


• 
  Autoimmune Disease Testing


• 
  Obstetrics Testing


• 
  Others

By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  NGS Platforms


• 
  RT-PCR


• 
  Microarray


• 
  Genetic Analyzers


• 
  Others

By End User [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  Academics & Research Institutes


• 
  Diagnostic Centers


• 
  Others

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  North America

• 
  United States


• 
  Canada


• 
  Mexico

• 
  Europe

• 
  United Kingdom


• 
  Spain


• 
  Germany


• 
  France

• 
  Asia Pacific

• 
  China


• 
  India


• 
  Japan

• 
  The Rest of the World

• 
  Brazil

 

This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.